Office of the Director, National Institutes of Health; Notice of Meeting, 70197 [2014-27822]

Download as PDF Federal Register / Vol. 79, No. 227 / Tuesday, November 25, 2014 / Notices Dated: November 19, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2014–27821 Filed 11–24–14; 8:45 am] Office of the Director, National Institutes of Health; Notice of Meeting BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Meeting wreier-aviles on DSK4TPTVN1PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Cures Acceleration Network Review Board. The meeting will be open to the public, viewing virtually by WebEx. Individuals can register to view and access the meeting by the link below. https:// ncatsevents.webex.com/ncatsevents/ onstage/g.php?MTID=eb948880d82d 5d6f0c3d3b5ad5cd7429e. 1. Go to ‘‘Event Status’’ on the left hand side of page, then click ‘‘Register’’. On the registration form, enter your information and then click ‘‘Submit’’ to complete the required registration. 2. You will receive a personalized email with the live event link. Name of Committee: Cures Acceleration Network Review Board. Date: December 12, 2014. Time: 11:00 a.m. to 1:00 p.m. Agenda: The CAN Review Board will meet virtually to discuss updates regarding CAN programs and next steps. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Danilo A. Tagle, Ph.D., Executive Secretary, National Center for Advancing Translational, Sciences, 1 Democracy Plaza, Room 992, Bethesda, MD 20892, 301–594–8064, Danilo.Tagle@nih.gov. This notice is being published less than 15 days prior to the meeting due to finalizing the agenda and scheduling of meeting topics. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Dated: November 19, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–27819 Filed 11–24–14; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 14:41 Nov 24, 2014 Jkt 235001 National Institutes of Health Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Recombinant DNA Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Recombinant DNA Advisory Committee. Date: December 11, 2014. Time: 8:30 a.m. to 5:00 p.m. Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will review and discuss selected human gene transfer protocols and related data management activities. Please check the meeting agenda at OBA Meetings Page (available at the following URL: https://oba.od.nih.gov/rdna_ rac/rac_meetings.html) for more information. Place: National Institutes of Health Building 45, Conference Room, E1/E2 9000, Rockville Pike, Bethesda, MD 20892. Contact Person: Chris Nice, Program Assistant, Office of Biotechnology Activities, National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, 301– 496–9838, nicelc@mail.nih.gov This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// oba.od.nih.gov/rdna/rdna.html, where an agenda and any additional information for the meeting will be posted when available. OMB’s ‘‘Mandatory Information Requirements for Federal Assistance Program Announcements’’ (45 FR 39592, June 11, 1980) requires a statement concerning the official government programs contained in the Catalog of Federal Domestic Assistance. Normally NIH lists in its announcements the number and title of affected individual programs for the guidance of the public. Because the guidance in this notice covers virtually every NIH and Federal research program in which DNA recombinant molecule techniques could be used, it has been determined not to be cost effective or PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 70197 in the public interest to attempt to list these programs. Such a list would likely require several additional pages. In addition, NIH could not be certain that every Federal program would be included as many Federal agencies, as well as private organizations, both national and international, have elected to follow the NIH Guidelines. In lieu of the individual program listing, NIH invites readers to direct questions to the information address above about whether individual programs listed in the Catalog of Federal Domestic Assistance are affected. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: November 19, 2014. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–27822 Filed 11–24–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY [Docket No DHS–2014–0066] Homeland Security Advisory Council— New Tasking The Office of Policy, DHS. Notice of task assignment for the Homeland Security Advisory Council. AGENCY: ACTION: The Secretary of the Department of Homeland Security (DHS), Jeh Johnson tasked his Homeland Security Advisory Council (HSAC) to establish a subcommittee entitled the DHS Grant Review Task Force on Friday November 7, 2014. The DHS Grant Review Task Force will provide recommendations to the Homeland Security Advisory Council on how to improve the allocation of annual grant funds among jurisdictions. This notice informs the public of the establishment of the DHS Grant Review Task Force and is not a solicitation for membership. FOR FURTHER INFORMATION CONTACT: Mike Miron, Director, Homeland Security Advisory Council and the DHS Grant Review Task Force at 202–447– 3135 or mike.miron@dhs.gov. SUMMARY: E:\FR\FM\25NON1.SGM 25NON1

Agencies

[Federal Register Volume 79, Number 227 (Tuesday, November 25, 2014)]
[Notices]
[Page 70197]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27822]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: December 11, 2014.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will 
review and discuss selected human gene transfer protocols and 
related data management activities. Please check the meeting agenda 
at OBA Meetings Page (available at the following URL: https://oba.od.nih.gov/rdna_rac/rac_meetings.html) for more information.
    Place: National Institutes of Health Building 45, Conference 
Room, E1/E2 9000, Rockville Pike, Bethesda, MD 20892.
    Contact Person: Chris Nice, Program Assistant, Office of 
Biotechnology Activities, National Institutes of Health, 6705 
Rockledge Drive, Suite 750, Bethesda, MD 20892, 301-496-9838, 
nicelc@mail.nih.gov
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: https://oba.od.nih.gov/rdna/rdna.html, where an agenda and any 
additional information for the meeting will be posted when 
available.
    OMB's ``Mandatory Information Requirements for Federal 
Assistance Program Announcements'' (45 FR 39592, June 11, 1980) 
requires a statement concerning the official government programs 
contained in the Catalog of Federal Domestic Assistance. Normally 
NIH lists in its announcements the number and title of affected 
individual programs for the guidance of the public. Because the 
guidance in this notice covers virtually every NIH and Federal 
research program in which DNA recombinant molecule techniques could 
be used, it has been determined not to be cost effective or in the 
public interest to attempt to list these programs. Such a list would 
likely require several additional pages. In addition, NIH could not 
be certain that every Federal program would be included as many 
Federal agencies, as well as private organizations, both national 
and international, have elected to follow the NIH Guidelines. In 
lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, Academic 
Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency 
Syndrome Research Loan Repayment Program; 93.187, Undergraduate 
Scholarship Program for Individuals from Disadvantaged Backgrounds, 
National Institutes of Health, HHS)

    Dated: November 19, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-27822 Filed 11-24-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.